PT Inquest is an online journal club. Hosted by Jason Tuori, Megan Graham, and Chris Juneau, the show looks at an article every week and discusses how it applies to current physical therapy practice.
…
continue reading
Content provided by UC San Diego Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC San Diego Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
n=17 Century-old drug tested in boys with autism
MP3•Episode home
Manage episode 180002737 series 1183616
Content provided by UC San Diego Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC San Diego Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In a small, clinical trial, a single dose of the drug suramin produced measurable, but transient, improvements in five boys with autism spectrum disorder (ASD). Here, lead researcher Robert K. Naviaux, MD, PhD, talks with Miles McInerney, a teenager with ASD who was involved in the study but did not receive suramin, and his mother, Kim Kennedy. They discuss the trial, why Miles wanted to participate, and his concerns about changing what makes him who he is. (Suramin is a 100-year-old drug developed to treat African sleeping sickness. It is not approved for any therapeutic use in the U.S. This trial was only intended to test the drug’s safety. Larger, longer clinical trials are needed to assess suramin or similar drugs as an ASD treatment. For more, visit: http://health.ucsd.edu/suramin)
…
continue reading
48 episodes
MP3•Episode home
Manage episode 180002737 series 1183616
Content provided by UC San Diego Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC San Diego Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In a small, clinical trial, a single dose of the drug suramin produced measurable, but transient, improvements in five boys with autism spectrum disorder (ASD). Here, lead researcher Robert K. Naviaux, MD, PhD, talks with Miles McInerney, a teenager with ASD who was involved in the study but did not receive suramin, and his mother, Kim Kennedy. They discuss the trial, why Miles wanted to participate, and his concerns about changing what makes him who he is. (Suramin is a 100-year-old drug developed to treat African sleeping sickness. It is not approved for any therapeutic use in the U.S. This trial was only intended to test the drug’s safety. Larger, longer clinical trials are needed to assess suramin or similar drugs as an ASD treatment. For more, visit: http://health.ucsd.edu/suramin)
…
continue reading
48 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.